Skip to content

Role of Urine Urge Suppression in Urinary tract infection. A survey Study

Role of Mutravega dharana in manifestation of Mutrakrichchhra (Urinary Tract Infection) - A Case Control Survey Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018480
Enrollment
300
Registered
2019-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

IPGT RA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: GROUP A(Control group) 1.General OPD patients coming to hospital other than Mutrkrichchhra.(Urinary Tract Infection) 2.Patients will be selected irrespective of any bar of caste, gender, religion and occupation etc. GROUP B (Case group): 1.The patients with the signs and symptoms of Mutrakrichchchhra as per Ayurveda as well as modern classics.

Exclusion criteria

Exclusion criteria: I.Group A(Control group) 1.Patients suffering from any severe systemic disease like prostate gland enlargement, hydrocele, Renal Failure etc. will be excluded. 2. Pregnant women. GROUP B (Case group): 1.Patients suffering from any severe systemic disease will be excluded like prostate gland enlargement, hydrocele, Renal Failure, etc. 2.Pregnant women.

Design outcomes

Primary

MeasureTime frame
The role of suppression of urine urge in the manifestation of Urinary Tract infection is to be evaluated.Timepoint: one year

Secondary

MeasureTime frame
1.Preparation of standard and validated questionnaire to assess the severity of suppression of urine urge.Timepoint: 3 months for questionnaire validation.

Countries

India

Contacts

Public ContactProf AS Baghel

IPGTRA GAU Jamnagar

asbaghel09@gmail.com7984780397

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026